Search For "pfizer biontech"
Booster dose of COVID-19 vaccine 95.6 pc effective, say Pfizer, BioNTech
Updated : 4 years, 4 months ago IST
Washington [US], October 21 (ANI): Pfizer and BioNTech said on Thursday that a booster shot of their COVID-19 vaccine has shown 95.6 per cent efficacy when compared to those who did not receive the booster dose.
Read More
US CDC panel endorses Pfizer booster shot for elderly, high-risk people
Updated : 4 years, 5 months ago IST
Washington [US], September 24 (ANI/Xinhua): A U.S. Centers for Disease Control and Prevention (CDC) advisory panel on Thursday endorsed booster doses of the Pfizer-BioNTech COVID-19 vaccine for Americans aged 65 and older and some adults with certain high risk conditions.
Read More
US FDA authorizes Pfizer's Covid booster shots for elderly, high-risk Amer
Updated : 4 years, 5 months ago IST
Washington [US], September 23 (ANI): US Food and Drug Administration (FDA) on Wednesday (local time) authorized booster shots of the Pfizer COVID-19 vaccine for those aged 65 and older and adults at high risk.
Read More
WHO emergency use authorisation to Covaxin delayed till October 5
Updated : 4 years, 5 months ago IST
New Delhi [India], September 18 (ANI): World Health Organisation's (WHO) approval for the emergency use authorisation (EUA) to COVID-19 vaccine Covaxin, developed by the Hyderabad-based Bharat Biotech, is likely to be delayed till October 5.
Read More
CDC panel endorses approval of the Pfizer Covid vaccine for Americans aged
Updated : 4 years, 6 months ago IST
Washington [US], August 31 (ANI/Sputnik): A key advisory panel of the US Centers for Disease Control and Prevention (CDC) said on Monday that it has unanimously endorsed the full approval of the Pfizer-BioNTech's COVID-19 vaccine for Americans aged 16 and older.
Read More
Pfizer jab side effects in 12 to 15-year-olds at high risk of COVID-19 com
Updated : 4 years, 6 months ago IST
London [UK], August 28 (ANI): A new study has revealed that the side effects of the Pfizer-BioNTech jab against COVID-19 in 12-15-year-olds at high risk of complications from the infection are likely to be mild to moderate and clear up quickly because of certain coexisting conditions.
Read More
Pfizer jab side effects in 12-15 year olds at high risk of COVID-19 compli
Updated : 4 years, 6 months ago IST
London [UK], August 27 (ANI): A new study has revealed that the side effects of the Pfizer-BioNTech jab against COVID-19 in 12-15-year-olds at high risk of complications from the infection are likely to be mild to moderate and clear up quickly because of certain coexisting conditions.
Read More
US: FDA gives full approval to Pfizer-BioNTech COVID 19 vaccine
Updated : 4 years, 6 months ago IST
Washington [US] August 23 (ANI): The US Food and Drug Administration (FDA) on Monday gave full approval to Pfizer's COVID-19 vaccine.
Read More
Pfizer and BioNTech announce submission of Initial data to US FDA to suppo
Updated : 4 years, 6 months ago IST
New York [US], August 17 (ANI): Pfizer and BioNTech announced that they have submitted Phase 1 data to the United States Food and Drug Administration (FDA) to support the evaluation of a third, or booster dose of the companies' COVID-19 vaccine for future licensure.
Read More
Cyprus starts COVID-19 vaccination for 12- to 15-year-olds
Updated : 4 years, 7 months ago IST
Nicosia [Cyprus], August 2 (ANI/Xinhua): Cyprus' Health Ministry said it on Monday started a vaccination program for 12- to 15-year-olds.
Read More
Efficacy of Pfizer/BioNTech coronavirus vaccine drops to 84pc after 6 mont
Updated : 4 years, 7 months ago IST
Washington DC [US], July 29 (ANI/Sputnik): The efficacy of the Pfizer/BioNTech coronavirus vaccine fell from 96% to 84% after six months, a new preprint report by medRxiv showed on Wednesday.
Read More
Pfizer, BioNTech to produce COVID-19 vaccine in South Africa
Updated : 4 years, 7 months ago IST
Washington [US], July 21 (ANI/Sputnik): Pfizer and BioNTech have signed an agreement with South Africa's Biovac Institute to produce the COVID-19 vaccine in South Africa for the African Union, Pfizer said in a statement on Wednesday.
Read More